EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

Butyrate‐Producing Bacteria in Intestinal Disease Therapy: Potential and Challenges

Fenfen Zhang, Wei Zhang, Xiaoting Ren, Bo Liu, Xiaolun Zhou iD

Biotechnology Journal · 2026-06 · 21 (6)

DOI: 10.1002/biot.70260 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Biotechnology Journal, online erschienen am 17.06.2026. Verfasst von Fenfen Zhang und 4 weiteren Autor:innen. Beteiligte Einrichtung: School of Clinical Medicine, Gansu Medical College, Pingliang, Gansu Province, China. Hauptthemen laut MEDLINE: Butyrates, Intestinal Diseases, Gastrointestinal Microbiome, Bacteria. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 113 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: 2025 Gansu Provincial University Teacher Innovation Fund Project: Omics-Based Study on the Molecular Regulatory Mechanism Between Gut Microbiota and β-Hydroxyb…, Director Responsibility System Project of Gansu Medical College: Isolation, Identification of Butyrate-Producing Bacteria in Animal Intestine and Their Molecul….

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Butyrate‐producing bacteria have emerged as keystone species whose metabolic activity orchestrates host‐microbial homeostasis in the human gut. This review synthesizes current understanding of how these anaerobic Firmicutes, including Faecalibacterium prausnitzii , Roseburia spp ., and Eubacterium rectale , function as key contributors to intestinal health through convergent mechanisms: serving as the primary energy source for colonocytes, enforcing mucosal hypoxia that excludes facultative pathogens, and modulating immunity via histone deacetylase inhibition and G‐protein‐coupled receptor signaling. We critically examine the translational trajectory of butyrogenic therapies across inflammatory bowel disease, colorectal cancer, and emerging applications in radiation injury, infection, and graft‐versus‐host disease. Despite compelling mechanistic rationale and consistent clinical associations linking butyrate‐producer depletion with disease activity, therapeutic translation faces formidable bottlenecks: extreme oxygen sensitivity complicates manufacturing; cross‐feeding networks necessitate ecological rather than monostrain approaches; and host context determines whether butyrate exerts protective or permissive effects. We evaluate cutting‐edge strategies to overcome these barriers, including rationally designed consortia, precision prebiotics, phage‐mediated niche engineering, synthetic biology approaches, and AI‐guided personalization. By integrating mechanistic insight with translational pragmatism, this review outlines a path toward evidence‐based butyrogenic therapies that may complement existing strategies for intestinal disease.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ButyratesIntestinal DiseasesGastrointestinal MicrobiomeBacteriaHumansAnimalsInflammatory Bowel Diseases

Stichwörter der Autor:innen

butyrate‐producing bacteriainflammatory bowel diseaselive biotherapeutic productsmicrobiome therapeuticsshort‐chain fatty acids

Substanzen

Butyrates

Autor:innen und Institutionen

  • School of Clinical Medicine, Gansu Medical College, Pingliang, Gansu Province, China.

ORCID-Profile: Xiaolun Zhou

Förderung

  • 2025 Gansu Provincial University Teacher Innovation Fund Project: Omics-Based Study on the Molecular Regulatory Mechanism Between Gut Microbiota and β-Hydroxyb…
  • Director Responsibility System Project of Gansu Medical College: Isolation, Identification of Butyrate-Producing Bacteria in Animal Intestine and Their Molecul…

Zitieren

APA

Zhang, F., Zhang, W., Ren, X., Liu, B., & Zhou, X. (2026). Butyrate‐Producing Bacteria in Intestinal Disease Therapy: Potential and Challenges. Biotechnology Journal, 21(6). https://doi.org/10.1002/biot.70260

Vancouver

Zhang F, Zhang W, Ren X, Liu B, Zhou X. Butyrate‐Producing Bacteria in Intestinal Disease Therapy: Potential and Challenges. Biotechnology Journal. 2026;21(6). doi:10.1002/biot.70260

BibTeX
@article{Zhang2026,
  author = {Zhang, Fenfen and Zhang, Wei and Ren, Xiaoting and Liu, Bo and Zhou, Xiaolun},
  title = {Butyrate‐Producing Bacteria in Intestinal Disease Therapy: Potential and Challenges},
  journal = {Biotechnology Journal},
  year = {2026},
  volume = {21},
  number = {6},
  doi = {10.1002/biot.70260}
}
Kostenlos starten →